HT
AGTC

HAP Trading’s Applied Genetic Technologies Corporation AGTC Stock Holding History

HAP Trading’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,100
Closed -$2K – 2508
2022
Q1 		$2K Buy
+17,100
New +$31.1K ﹤0.01% 2093
2021
Q3 		– Sell
-42,000
Closed -$4K – 2890
2021
Q2 		$4K Sell
42,000
-14,300
-25% -$59.3K ﹤0.01% 2205
2021
Q1 		$28K Buy
56,300
+38,200
+211% +$198K ﹤0.01% 1354
2020
Q4 		$3K Buy
18,100
+3,300
+22% +$16.2K ﹤0.01% 2102
2020
Q3 		$7K Buy
14,800
+400
+3% +$2.19K ﹤0.01% 1392
2020
Q2 		$10K Buy
+14,400
New +$66K ﹤0.01% 1456

Other funds holding AGTC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return